244 related articles for article (PubMed ID: 186677)
21. Effects of penfluridol of dopamine-sensitive adenylate cyclase in corpus striatum and substantia nigra of rats.
Seeber U; Kuschinsky K
Experientia; 1976 Dec; 32(12):1558-9. PubMed ID: 191279
[TBL] [Abstract][Full Text] [Related]
22. Regulation of dopamine receptor sensitivity by an endogenous protein activator or adenylate cyclase.
Costa E; Gnegy MG; Uzunov P
Naunyn Schmiedebergs Arch Pharmacol; 1977; 297 Suppl 1():S47-8. PubMed ID: 193053
[No Abstract] [Full Text] [Related]
23. Effect of lysolecithin of guanylate and adenylate cyclase activities in neuroblastoma cells in culture.
Zwiller J; Ciesielski-Treska J; Mandel P
FEBS Lett; 1976 Oct; 69(1):286-90. PubMed ID: 11126
[No Abstract] [Full Text] [Related]
24. Adenylate cyclase sensitivity to catecholamines and forskolin in rat pia-arachnoid and cerebral microvessels.
Palmer GC; Palmer SJ
Neuropharmacology; 1983 Feb; 22(2):213-9. PubMed ID: 6300722
[TBL] [Abstract][Full Text] [Related]
25. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
Hungen KV; Roberts S; Hill DF
Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
[TBL] [Abstract][Full Text] [Related]
26. Correlation between adenosine 3',5'-cyclic monosphosphate levels, adenylate cyclase activity, and adenosine 3',5'-cyclic monophosphate phosphodiesterase activity in tissue culture cells stimulated by serum.
Matsumoto T; Uchida T
J Biochem; 1975 Oct; 78(4):811-5. PubMed ID: 175046
[TBL] [Abstract][Full Text] [Related]
27. Effect of partially purified NSILA on adenylate cyclase, phosphodiesterase and 3',5'-cyclic AMP in fat cells.
Hepp KD; Renner R; Langley J; Häring HU
Mol Cell Endocrinol; 1975 Oct; 3(4):309-21. PubMed ID: 172393
[TBL] [Abstract][Full Text] [Related]
28. Substantia nigra of the rat contains a dopamine sensitive adenylate cyclase.
Phillipson OT; Horn AS
Nature; 1976 Jun; 261(5559):418-20. PubMed ID: 934274
[No Abstract] [Full Text] [Related]
29. Interactions of gangliosides with adenylate cyclase and cyclic AMP phosphodiesterase in rat brain homogenates and synaptosomes [proceedings].
Lovely JR; Butt NM; Saeed SA
Biochem Soc Trans; 1980 Feb; 8(1):128-9. PubMed ID: 6245952
[No Abstract] [Full Text] [Related]
30. An improved, automated adenylate cyclase assay utilizing preparative HPLC: effects of phosphodiesterase inhibitors.
Schulz DW; Mailman RB
J Neurochem; 1984 Mar; 42(3):764-74. PubMed ID: 6319607
[TBL] [Abstract][Full Text] [Related]
31. Effect of salt loading in the rat on adenylate cyclase and phosphodiesterase activity in kidney cortex, medulla and papilla.
Wald H; Gutman Y; Czaczkes W
Enzyme; 1977; 22(5):336-40. PubMed ID: 196846
[TBL] [Abstract][Full Text] [Related]
32. Decreased adenosine cyclic 3',5'-monophosphate phosphodiesterase activity in rat straitum following chronic haloperidol treatment.
Fredholm BB
Med Biol; 1977 Feb; 55(1):61-5. PubMed ID: 191703
[TBL] [Abstract][Full Text] [Related]
33. Is the dopamine sensitive adenylate cyclase in the rat substantia nigra coupled with 'autoreceptors'?
Premont J; Thierry AM; Tassin JP; Glowinski J; Blanc G; Bockaert J
FEBS Lett; 1976 Sep; 68(1):99-104. PubMed ID: 964385
[No Abstract] [Full Text] [Related]
34. Thyroid hormone control of cyclic nucleotide phosphodiesterases and the regulation of the sensitivity of the liver to hormones.
Gumaa KA; Hothersall JS; Greenbaum AL; McLean P
FEBS Lett; 1977 Aug; 80(1):45-8. PubMed ID: 196928
[No Abstract] [Full Text] [Related]
35. Diurnal rhythm in rat pineal cyclic nucleotide phosphodiesterase activity.
Minneman KP; Iversen LL
Nature; 1976 Mar; 260(5546):59-61. PubMed ID: 177878
[No Abstract] [Full Text] [Related]
36. Characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the frontal cerebral cortex of the rat. Comparative effects of neuroleptics on frontal cortex and striatal dopamine sensitive adenylate cyclases.
Bockaert J; Tassin JP; Thierry AM; Glowinski J; Premont J
Brain Res; 1977 Feb; 122(1):71-86. PubMed ID: 837225
[TBL] [Abstract][Full Text] [Related]
37. Discussion: Nigrostriatal projections and the "dopamine report".
Adinolfi AM
UCLA Forum Med Sci; 1975; (18):265-71. PubMed ID: 173061
[No Abstract] [Full Text] [Related]
38. [Effect of etimizol on rat brain adenyl cylase and 3',5'-adenosine monophosphate phosphodiesterase activity].
Migas EA; Bul'on VV
Farmakol Toksikol; 1974; 37(6):710-1. PubMed ID: 4377131
[No Abstract] [Full Text] [Related]
39. Receptor-linked cyclic AMP systems in rat neostriatum: differential localization revealed by kainic acid injection.
Minneman KP; Quik M; Emson PC
Brain Res; 1978 Aug; 151(3):507-21. PubMed ID: 27287
[TBL] [Abstract][Full Text] [Related]
40. Correlation between drug-induced supersensitivity of dopamine dependent striatal mechanisms and the increase in striatal content of the Ca2+ regulated protein activator of cAMP phosphodiesterase.
Gnegy ME; Lucchelli A; Costa E
Naunyn Schmiedebergs Arch Pharmacol; 1977 Dec; 301(2):121-7. PubMed ID: 202883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
